A striking feature of KRAS KO tumor cells was a significant 2–10-fold increase in MHC gene expression (H2d1, H2k1, B2m, and H2-aa, H2-ab1, CD74) over KRAS intact controls (Fig. 3c). This evidence concerns the gene KRAS and neoplasm.